Trending Now
Titan Pharmaceuticals Inc. (NASDAQ:TTNP) Winds Down Probuphine sales In The US...
Titan Pharmaceuticals Inc. (NASDAQ:TTNP) has announced a strategic restructuring that will see its focus on product development of ProNeur®. This is in a bid...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Spectrum Therapeutics Inc. (NASDAQ:SPPI) Announced Q3 2020 Results And Poziotinib and...
Spectrum Therapeutics Inc. (NASDAQ:SPPI) has announced its financial results for the third quarter ended September 30, 2020.
FDA to review poziotinib NDA
Joe Turgeon the company's...
MAKE IT MODERN
LATEST REVIEWS
Harmonic Inc (NASDAQ: HLIT) Announces $2.1 Million in Income During The...
Harmonic Inc (NASDAQ: HLIT) recently announced its unaudited results in 2Q2021. The company reported a revenue of $113.4 million, a 53% year-over-year increase.
Financial summary
According...
MAKE IT MODERN
PERFORMANCE TRAINING
Why Clubhouse Media (CMGR) Could be a “Steal” at Current Levels
The story associated with Clubhouse Media Group Inc (OTCMKTS:CMGR) is still developing as a market narrative, but it is nonetheless a fascinating...
Novus Therapeutics Inc. (NASDAQ:NVUS) Shares Tank After OP0201 Study In Acute Otitis Media Results...
Novus Therapeutics Inc. (NASDAQ:NVUS) shares lost almost 50% of its value after the company delivered disappointing results of its Phase 2a exploratory clinical study...
Clovis Oncology Inc. (NASDAQ:CLVS) Sets out a Phase 2 Portion of the LIO-1 Trial...
Clovis Oncology Inc. (NASDAQ:CLVS) is an active participant in the development of innovative anti-cancer agents. It has a strong presence in the U.S., Europe,...
AIM ImmunoTech Inc. (NYSEAMERICAN:AIM) Reports Study Progress of Ampligen Combination As COVID-19 Treatment
AIM ImmunoTech Inc. (NYSEAMERICAN:AIM) has announced positive development in advancing preventive strategies and treatment for SARS-CoV-2 caused by COVID-19 disease.
ChargePoint Holdings Inc (NYSE:CHPT) unusual options activity indicates increased interest
CPI number that we see this morning is going to make an impact in the market one way or another. Stocks have...





















































